Alliance Pharma PLC Annual Report and Notice of AGM (4823E)

TIDMAPH

RNS Number : 4823E

Alliance Pharma PLC

10 April 2014

 
 For immediate release   10 April 2014 
 

ALLIANCE PHARMA PLC

(the "Company")

Annual Report and AGM Notice

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce that its 2013 Annual Report and Accounts and Notice of Annual General Meeting, which will be held on 21 May 2014, are now available on the Company's website at www.alliancepharma.co.uk

Printed copies of both documents will be posted to shareholders shortly and may also be requested by email at [e-mail].

For further information:

 
 Alliance Pharma plc                         + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
 Richard Wright, Finance Director 
 www.alliancepharma.co.uk 
 Buchanan                                   + 44 (0) 20 7466 5000 
 Mark Court / Fiona Henson / Sophie 
  Cowles 
 
 Numis Securities Limited                   + 44 (0) 20 7260 1000 
 Nominated Adviser: Michael Meade / Oliver Cardigan 
  / Freddie Barnfield 
 Corporate Broking: David Poutney 
 
 

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCILMFTMBTMBPI